Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
In Vitro Activity of Delafloxacin and Finafloxacin against Mycoplasma hominis and Ureaplasma Species.
mutations in quinolone resistance determining region
Emerging Treatment Options for Mycoplasma genitalium Infections
Mutations in the parC gene are associated with fluoroquinolone resistance.
Antimicrobial susceptibility and genetic mechanisms of resistance of Ureaplasma isolates in North America between 2012 and 2023.
Epidemic and molecular characterization of fluoroquinolone-resistant Shigella dysenteriae 1 isolates from calves with diarrhea.
Phenotypic Antimicrobial Susceptibility and Genotypic Characterization of Clinical Ureaplasma Isolates Circulating in Shanghai, China.
Found in 22 FQ-resistant UPA isolates and 3 FQ-resistant UUR isolates.
Eradication of Helicobacter pylori reshapes gut microbiota and facilitates the evolution of antimicrobial resistance through gene transfer and genomic mutations in the gut.
Genomic mutations in parC contributed to resistance to nalidixic acid and ciprofloxacin.
Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland.
Detected in U. parvum serovar 6
Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013.
In vitro Activities of Nemonoxacin and Other Antimicrobial Agents Against Human Mycoplasma and Ureaplasmas Isolates and Their Defined Resistance Mechanisms.
Mutations in parC were found in M. hominis and Ureaplasma spp. isolates
Spread of multidrug resistance among Ureaplasma serovars, Tunisia.
Antimicrobial resistance, genetic characterization, and molecular epidemiology of Ureaplasma species in males with infertility.
Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysis.
mutations in parC gene associated with fluoroquinolone resistance
Antimicrobial Susceptibility and Clonality of Clinical Ureaplasma Isolates in the United States.
Prevalence of Mycoplasma genitalium Infection, Antimicrobial Resistance Mutations, and Symptom Resolution Following Treatment of Urethritis.
Quinolone-associated mutations in parC
Antimicrobial Resistance in Clinical Ureaplasma spp. and Mycoplasma hominis and Structural Mechanisms Underlying Quinolone Resistance.
mutations in ParC are associated with quinolone resistance
The prevalence and mechanism of fluoroquinolone resistance in Escherichia coli isolated from swine farms in China.
Mutations in the QRDR region
MYCO WELL D-ONE detection of Ureaplasma spp. and Mycoplasma hominis in sexual health patients in Wales.
The Ser83Leu mutation in parC is responsible for levofloxacin resistance in Ureaplasma spp.
In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.
Ureaplasma urealyticum parC conferring resistance to fluoroquinolones; CARD accession: CARD:3003309
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research